Panolos Bioscience Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

Panolos Bioscience General Information

Description

Developer of multi-specific drug creation platform designed for cancer treatment. The company's platform offers anti-angiogenesis-based artifact re-targeting tri-specifics commonly called ART, reducing the side effects of single-target protein therapeutics, and is a platform for the expansion of new drug pipelines through multi-targeting, enabling patients with novel drugs and treatment for cancer.

Contact Information

Website
www.panolos.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 21 gil 10 Dongtandae-ro
  • The First Tower, Suite#217
  • Hwaseong, Gyeonggi 18471
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 21 gil 10 Dongtandae-ro
  • The First Tower, Suite#217
  • Hwaseong, Gyeonggi 18471
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Panolos Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 17-May-2021 Completed Clinical Trials - Phase 1
2. Early Stage VC 01-Sep-2020 $50.5M $54.8M Completed Startup
1. Angel (individual) 01-Feb-2020 $4.28M $4.28M Completed Startup
To view Panolos Bioscience’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Panolos Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of multi-specific drug creation platform designed for cancer treatment. The company's platform offers anti-ang
Drug Discovery
Hwaseong, South Korea
6 As of 2025

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Panolos Bioscience Competitors (1)

One of Panolos Bioscience’s competitors is Shattuck Labs, a Formerly VC-backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Shattuck Labs Formerly VC-backed Austin, TX
You’re viewing 1 of 1 competitors. Get the full list »

Panolos Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Panolos Bioscience Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cloud Ivy Investment Corporation Minority
Compa Ventures Venture Capital Minority
JL Partners Venture Capital Minority
K-Clavis Asset Manager Minority
KOC Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Panolos Bioscience FAQs

  • When was Panolos Bioscience founded?

    Panolos Bioscience was founded in 2019.

  • Where is Panolos Bioscience headquartered?

    Panolos Bioscience is headquartered in Hwaseong, South Korea.

  • What is the size of Panolos Bioscience?

    Panolos Bioscience has 6 total employees.

  • What industry is Panolos Bioscience in?

    Panolos Bioscience’s primary industry is Drug Discovery.

  • Is Panolos Bioscience a private or public company?

    Panolos Bioscience is a Private company.

  • What is Panolos Bioscience’s current revenue?

    The current revenue for Panolos Bioscience is .

  • How much funding has Panolos Bioscience raised over time?

    Panolos Bioscience has raised $72.7M.

  • Who are Panolos Bioscience’s investors?

    Cloud Ivy Investment, Compa Ventures, JL Partners, K-Clavis, and KOC Partners are 5 of 8 investors who have invested in Panolos Bioscience.

  • Who are Panolos Bioscience’s competitors?

    Shattuck Labs is a competitor of Panolos Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process